C-MER Medical Holdings Limited reported a minor adjustment to its share capital following an on-market share repurchase conducted on 4 November 2026 under its existing mandate dated 20 May 2026.

The company bought back 120,000 ordinary shares on the Stock Exchange of Hong Kong at prices ranging between HKD 0.895 and HKD 0.900, representing a volume-weighted average purchase price of HKD 0.8978 per share. Total consideration amounted to HKD 0.11 million.

Post-transaction, the number of issued shares (excluding treasury shares) declined by 0.0099 % to 1.20693 billion, while treasury shares increased by the same volume to 25.41 million. The overall issued share count, including treasury shares, remained unchanged at 1.23234 billion.

The latest repurchase utilises approximately 0.10 % of the 123.23 million-share buyback authority granted by shareholders, leaving more than 99 % of the mandate available. In accordance with Hong Kong listing rules, C-MER Medical is restricted from issuing new shares or selling treasury shares until 4 December 2026.